» Articles » PMID: 38214084

Epidemic in Denmark, October to December, 2023

Overview
Journal Euro Surveill
Date 2024 Jan 12
PMID 38214084
Authors
Affiliations
Soon will be listed here.
Abstract

We report a surge of patients, especially children and adolescents, with respiratory disease caused by in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to infections has been established to inform the healthcare system, decisionmakers and the public.

Citing Articles

Persistently high burden of acute respiratory infections requiring hospitalization in German pediatric hospitals, fall/winter 2023-2024.

Dressen S, Schneider J, Doenhardt M, Diffloth N, Tenenbaum T, Schneider D Infection. 2025; .

PMID: 40064762 DOI: 10.1007/s15010-025-02494-z.


Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany.

Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J BMC Infect Dis. 2025; 25(1):318.

PMID: 40050786 PMC: 11884198. DOI: 10.1186/s12879-025-10657-4.


Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.

Leber A, Embry T, Everhart K, Taveras J, Oyeniran S, Wang H Emerg Infect Dis. 2025; 31(3):555-558.

PMID: 40023809 PMC: 11878328. DOI: 10.3201/eid3103.241570.


Mycoplasma pneumoniae MLST detected in the upsurge of pneumonia during the 2023 to 2024 winter season in the Netherlands.

Smit P, Eggink D, Paltansing S, Hooiveld M, van Gageldonk-Lafeber A, Dunk D Sci Rep. 2025; 15(1):6985.

PMID: 40011487 PMC: 11865550. DOI: 10.1038/s41598-025-88990-6.


The value of common blood parameters for the differential diagnosis of respiratory tract infections in children.

Ma J, Tian T, Zeng N, Gu Y, Ren X, Jin Z AMB Express. 2025; 15(1):25.

PMID: 39918743 PMC: 11806179. DOI: 10.1186/s13568-025-01829-1.


References
1.
Loconsole D, De Robertis A, Sallustio A, Centrone F, Morcavallo C, Campanella S . Update on the Epidemiology of Macrolide-Resistant in Europe: A Systematic Review. Infect Dis Rep. 2021; 13(3):811-820. PMC: 8482213. DOI: 10.3390/idr13030073. View

2.
Munkstrup C, Lomholt F, Emborg H, Moller K, Krog J, Trebbien R . Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022. Euro Surveill. 2023; 28(1). PMC: 9817209. DOI: 10.2807/1560-7917.ES.2023.28.1.2200937. View

3.
Meyer Sauteur P, Chalker V, Berger C, Nir-Paz R, Beeton M . Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?. Lancet Microbe. 2022; 3(12):e897. PMC: 9371584. DOI: 10.1016/S2666-5247(22)00190-2. View

4.
Yu H, Zhao M, Pu Z, Ju Y, Liu Y . A study of community-acquired in Yantai, China. Colomb Med (Cali). 2018; 49(2):160-163. PMC: 6084921. DOI: 10.25100/cm.v49i2.3813. View

5.
Hatter L, Eathorne A, Hills T, Bruce P, Beasley R . Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health. 2021; 5(12):e44-e45. PMC: 8598182. DOI: 10.1016/S2352-4642(21)00333-3. View